Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 2 | 2021 | 171 | 1.110 |
Why?
|
| Heart Arrest | 3 | 2015 | 32 | 0.770 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 102 | 0.720 |
Why?
|
| Electrocardiography | 3 | 2015 | 154 | 0.620 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 35 | 0.500 |
Why?
|
| Odds Ratio | 1 | 2015 | 517 | 0.460 |
Why?
|
| Telemetry | 2 | 2015 | 14 | 0.270 |
Why?
|
| Heart Rate | 2 | 2015 | 248 | 0.240 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 55 | 0.210 |
Why?
|
| Ventricular Fibrillation | 2 | 2014 | 8 | 0.190 |
Why?
|
| Humans | 14 | 2021 | 34853 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2017 | 1349 | 0.160 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 394 | 0.150 |
Why?
|
| Female | 10 | 2017 | 19873 | 0.150 |
Why?
|
| Heart Conduction System | 2 | 2014 | 14 | 0.140 |
Why?
|
| Weather | 1 | 2015 | 7 | 0.140 |
Why?
|
| HIV Infections | 2 | 2021 | 2207 | 0.140 |
Why?
|
| Dysmenorrhea | 1 | 2015 | 3 | 0.130 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 59 | 0.130 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 2 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2015 | 65 | 0.130 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 27 | 0.130 |
Why?
|
| Analgesics | 1 | 2015 | 56 | 0.130 |
Why?
|
| Dengue Virus | 1 | 2015 | 84 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 33 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2014 | 57 | 0.120 |
Why?
|
| Patient Discharge | 1 | 2014 | 92 | 0.120 |
Why?
|
| Dengue | 1 | 2015 | 93 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2014 | 1961 | 0.120 |
Why?
|
| Linear Models | 2 | 2012 | 253 | 0.110 |
Why?
|
| Tourniquets | 1 | 2012 | 1 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 1 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2012 | 13 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 292 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 13 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 531 | 0.110 |
Why?
|
| Aged | 5 | 2015 | 6448 | 0.110 |
Why?
|
| Pain | 1 | 2015 | 249 | 0.110 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 15 | 0.100 |
Why?
|
| Musculoskeletal System | 1 | 2011 | 8 | 0.100 |
Why?
|
| Middle Aged | 6 | 2017 | 9642 | 0.100 |
Why?
|
| Clavicle | 1 | 2010 | 3 | 0.100 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2010 | 4 | 0.100 |
Why?
|
| Bone Nails | 1 | 2010 | 5 | 0.100 |
Why?
|
| Protons | 1 | 2011 | 80 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 2 | 0.100 |
Why?
|
| Bone Screws | 1 | 2010 | 7 | 0.100 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 7 | 0.100 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2010 | 6 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2010 | 51 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2010 | 59 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2010 | 30 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 281 | 0.090 |
Why?
|
| Premature Birth | 1 | 2010 | 71 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2010 | 528 | 0.080 |
Why?
|
| Child | 3 | 2011 | 2875 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2010 | 871 | 0.080 |
Why?
|
| Risk Factors | 1 | 2014 | 3414 | 0.070 |
Why?
|
| Adult | 6 | 2021 | 11034 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2021 | 628 | 0.070 |
Why?
|
| Young Adult | 4 | 2021 | 4012 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2005 | 20 | 0.070 |
Why?
|
| Adolescent | 4 | 2021 | 5035 | 0.070 |
Why?
|
| Pregnancy | 1 | 2010 | 1503 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 74 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 182 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 36 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 74 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 59 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 2333 | 0.050 |
Why?
|
| DNA | 1 | 2005 | 549 | 0.050 |
Why?
|
| Heart | 1 | 2003 | 178 | 0.050 |
Why?
|
| United States | 1 | 2010 | 3894 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 233 | 0.050 |
Why?
|
| Uganda | 1 | 2017 | 22 | 0.040 |
Why?
|
| Rural Health Services | 1 | 2017 | 39 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2017 | 110 | 0.040 |
Why?
|
| Counseling | 1 | 2017 | 105 | 0.040 |
Why?
|
| Peru | 1 | 2015 | 26 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2017 | 182 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 438 | 0.030 |
Why?
|
| Rural Population | 1 | 2017 | 253 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 124 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hematocrit | 1 | 2012 | 18 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2012 | 101 | 0.030 |
Why?
|
| Shoulder Joint | 1 | 2010 | 2 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 30 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 26 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Radiography | 1 | 2010 | 75 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 89 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 424 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 570 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 14307 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 964 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 1318 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 2003 | 10 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2003 | 9 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 597 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 129 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 92 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2003 | 93 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 194 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 219 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 1300 | 0.010 |
Why?
|